Innovating the Process To Drive Progress.
Typically, patients do not learn about clinical research from their physicians unless their physicians are directly engaged in clinical research. This has a direct and adverse impact on trial enrollment rates; hindering timely delivery of breakthrough new therapies to patients.
Today, less than 1% of the U.S. population participates in clinical research, yet 72% say they would participate if recommended to do so by their physician.
Through our high-value healthcare partnerships, we are:
Allowing for expanded access to providers and patients
Delivering a standardized service platform
Reducing time, risks, and costs traditionally associated with clinical trials and site performance
Javara provides a comprehensive, reliable clinical research delivery model to innovate the clinical trial experience for healthcare systems and patients, while effectively and efficiently advancing the drug development process. By better connecting physicians, patients, and the biopharmaceutical enterprise, our model represents a paradigm shift leading to increased clinical trial awareness, access and participation.
The Business of Clinical Research Is Under Pressure:
of trials are not completed on time
of trials are delayed due to patient enrollment issues
of physician researchers leave clinical research after a single trial
Javara’s next generation Integrated Research Organization (IRO) model optimizes the drug development process through a platform built to better engage healthcare systems, providers and patients in research participation.